Pharmaceutical Processing

Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia. The new site, just west of Richmond, will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly’s emerging bioconjugate platform and monocloncal antibody portfolio, according to a news…

Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in…

Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility…

Optel Group announced that it acquired Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. The acquisition reinforces Optel’s commitment to pharmaceutical automation as a leader in traceability and supply chain solutions. By integrating Vanguard’s robotics technology, Optel believes it can help pharmaceutical manufacturers address labor constraints. It also expects the deal to enhance…

Roche and its Genentech unit today announced the groundbreaking for its newest U.S. manufacturing site in Holly Springs, North Carolina. Genentech said the development marks the establishment of its first manufacturing facility on the East Coast. It designed the 65,000-square-meter facility to support the production of its future portfolio of metabolic medicines. Those include next-generation…

Cambrex announced today that its Snapdragon Chemistry company expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts. The expansion further supports the development and manufacturing of peptide therapies. East Rutherford, New Jersey-based Cambrex said its new GMP manufacturing suite increases the overall facility footprint by 20%. It also includes an ISO-7 cleanroom for preparative…

Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately…

ChemPartner today announced plans for its strategic expansion in the U.S. with a new Boston Center of Excellence. Located at 480 Arsenal way in Watertown, Massachusetts, just outside of Boston, the new R&D site will commence operations on Sept. 10. The Shanghai-based CRO and CDMO plans to use the site to provide discovery and preclinical…

AbbVie (NYSE:ABBV) announced today that it invested $195 million to expand domestic active pharmaceutical ingredient (API) production. The company’s investment comes in its North Chicago, Illinois, plant to advance its U.S. API manufacturing. This expansion comes as part of AbbVie’s commitment to invest more than $10 billion in the U.S. to broadly support innovation and…

Bionova Scientific, a subsidiary of Asahi Kasei, today announced the opening of a new plasmid DNA (pDNA) production facility in The Woodlands, Texas. The 10,000-square-foot, state-of-the-art development and production facility sits less than 30 miles north of Houston. It designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. pDNA…